Pharmacist Intervention to Address Drug Related Problems in Patients with Decompensated Liver Cirrhosis

Background: Patients with decompensated cirrhosis are often given therapeutic and prophylactic drugs. Polypharmacy raises both the likelihood of prescription errors complications associated Clinical pharmacists excellent at recognizing, addressing, preventing clinically significant drug-related problems. Objectives: Identification types pharmacist interventions to address problems in patients assess acceptance/implementation these recommendations. And identify patient factors accepting Subjects Methods: Prospective, interventional, clinical study for 80 hospitalized was conducted Baghdad Teaching Hospital lasted four months, from first December 2021 until last March 2022. The involved two phases, one observational classify them according Pharmaceutical Care Network Europe classification version 9.1, second phase interventional increase awareness health care providers about those propose a proper solution each one. Results: most frequent intervention proposed prescriber (54.7%), followed by speaking caregiver (37.7%). Acceptance full implementation were highly observed 71.1% intervention. There is association between occurring ascites bleeding accepting/implementing recommendations Conclusions: liver have prevalence recognizing reducing their incidence, well accepted.